Neratinib maleate is the maleate salt form of neratinib, an orally available, irreversible inhibitor of the receptor tyrosine kinases HER2 and EGFR. It is used as an active pharmaceutical ingredient in the manufacturing of pharmaceutical products, targeting HER2- and EGFR-expressing tumor cells.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 915942-22-2
Neratinib
pharmaceutical raw material
Pyrotinib
pharmaceutical raw material
Shr-1258 dimaleate
pharmaceutical raw material
(3R,4R)-benidipine hydrochloride
pharmaceutical raw material
(17S)-methylnaltrexone bromide
pharmaceutical raw material
2-Tolperisone Hydrochloride
pharmaceutical raw material
Bromfenac
pharmaceutical raw material
4-[4-[(2-Pyridyl)methoxy]-3-chloroanilino]-6-amino-3-cyano-7-ethoxyquinoline
pharmaceutical raw material
(Z)-but-2-enedioic acid;(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
VXZCUHNJXSIJIM-MEBGWEOYSA-N
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C.C(=C\C(=O)O)\C(=O)O